Integrated Biopharma Inc
INBP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001016504
No open-market purchases or sales by Integrated Biopharma Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Integrated Biopharma Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Integrated Biopharma Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Friedman Eric J | Director | – | Jun 25, 2026 | 1 |
| Canarick Robert | Director | 234,233 | Jun 25, 2026 | 1 |
| Milmoe William H. | Director | 138,667 | Jun 25, 2026 | 3 |
| DeSantis Damon | Director, 10% Owner | 12,733,058Indirect | Jun 25, 2026 | 3 |
| Desantis Carl | 10% Owner | 0Indirect | Apr 17, 2026 | 2 |
| Riva Sheppard | Co-Chief Executive Officer | 1,473,467 | Dec 10, 2025 | 1 |
| Kay Christina | Co-Chief Executive Officer | 1,473,467 | Dec 10, 2025 | 1 |
| Masi Dina | Chief Financial Officer | 347,200 | Dec 10, 2025 | 1 |
| Kay E Gerald | Executive Chairman & President | 5,345,889 | Nov 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.